Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2025-12-25 @ 12:53 AM
NCT ID:
NCT01359267
Eligibility Criteria:
Inclusion Criteria:
* Treatment naive patients with histologically proven cancer of the head and neck
* T4 primary tumor (all sites), N2 or N3 locoregional disease (all sites)
* At least one measurable site of disease
* At least 18 years of age
* Karnofsky performance status \> or = 70% or ECOG \<2
* Able to tolerate SPECT/CT imaging
* Adequate bone marrow function
* Adequate liver function
* Adequate renal function
* Written consent from patients
* Female patients of childbearing potential must have a negative pregnancy test within 0-7 days prior to the first SPECT study
Exclusion Criteria:
* Diabetics with insulin dependence or blood sugar levels \>200 mg/dL prior to imaging
* Patient weight above the SPECT/CT table weight limit
* Pregnant and/or lactating female
* Unequivocal demonstration of metastatic disease
* Patients unwilling to or unable to comply with protocol
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01359267
Study Brief:
Protocol Section:
NCT01359267